BRIEF-Cytodyn receives orphan drug designation for PRO 140
October 05, 2017 at 06:17 AM EDT
* Cytodyn receives orphan drug designation for PRO 140 for prevention of graft versus host disease Source text for Eikon: Further company coverage: